## **WESSEX MULTIPLE SCLEROSIS THERAPY CENTRE** 

Report **2021** 



“I visit the therapy centre for weekly physio and oxygen therapy. I love the happy and friendly environment and I know the therapies help me to keep active and out of a wheelchair for longer” Mary Trimarco 

## **Registered Office** 

Bradbury House The Avenue Warminster Wiltshire BA12 9AB 

01985 217728 info@wessexms.co.uk www.wessexms.co.uk Registered Charity No. 800851 Registered Company No. 2315305 Fundraising Regulator No. 002357 

## **OUR ORGANISATION** 

The therapy centre is a regional charity offering physical, emotional and social therapies for people with MS and other conditions. There are currently over 250 regular members using the charity who live within an area covering Yeovil in the West, Andover in the East, Bath to the North and Bournemouth in the South. The members are mostly those living with MS, but those with other conditions do join for therapies where we have spare capacity, particularly oxygen therapy. 

Offering long term physiotherapy for members with MS and oxygen therapy for all members, the charity is a busy hive of activity. The charity also offers holistic therapies to families and carers to include massage therapy and reflexology. There is a pilates and dance class, and counselling is also available to all members. Other therapies on offer include reiki, touch therapy, cupping, and energy therapy. The charity provides a companion in the home with the MS Buddy Scheme for those living in social isolation and there is a warm and friendly purpose-built centre for social connection, relaxation and tea and cake. 

## **OUR OBJECTIVES** 

## **Independent Financial Examiners** 

PG Owen Limited 21a Market Place Warminster Wiltshire BA12 9AY 

## **Bankers** 

Lloyds Bank 37 Market Place Warminster Wiltshire BA12 9BD 

National Westminster Bank 4 Market Place Frome Somerset BA11 1AE 

Ultimately, we want to create a better quality of life for all our members, their carers and families. We understand how important it is to support the carer as well as the member, and the therapy centre strives to include everyone in need. 

By offering the MS Buddy Scheme we want to reach out to those members who have become socially isolated, perhaps through an MS relapse or illness, and help them to re-engage with their community and help them back into the therapy centre for much needed therapies. 

We want to provide a safe and happy space for those whose mobility and lifestyle has been compromised through ongoing illness and for them to find physical and emotional well-being in a supportive and friendly environment. 

## **Investment Managers** 

CCLA Senator House 85 Queen Victoria Street London EC4V 4ET 

- 2 - 



## **Trustees** 

## **CHAIR’S REPORT** 

During the year 2021 we endured the very sad loss of our chairman, Richard Southwell. Richard died on Monday 26 December and had attended a remote meeting with Rosie on the previous Wednesday, showing he cared for the MS Centre very much, almost to his dying day. This charity owes a great debt of gratitude to Richard and all that he did for the Centre, his grace and kindness was endless, he is sadly missed. 

The MS Centre managed to reopen under Covid restriction in July 2020 and 2021 proved to be a very complicated and challenging time for the charity. Thanks to the careful management from the team of staff working with Richard and the trustees, the MS Centre kept delivering therapies during this time. 

Due to social distance restrictions most of the therapies operated at a reduced capacity and the process of allowing members in and out of the building was timed to perfection. PPE was in place at all times and the charity continued to provide the much needed service to the community we serve. 

However, demand for our therapies, especially oxygen therapy, increased far beyond capacity and the trustees would like to give great thanks to the staff and volunteers for managing this very demanding situation throughout 2021. 

As a self-funding charity, the MS Centre found itself at the mercy of the financial constraints of operating during a pandemic and with careful applications to local government, especially Wiltshire Council and the Wiltshire Community Foundation the charity was able to continue operating and delivered over 8,000 therapies. 

Richard Southwell QC 

_(Chairman, deceased December 2021)_ Mike Davidson _(Acting Chair)_ Dr Brian Mansfield Sue Fraser Harry Hassall Trevor Woodyatt Amanda Cheesley 

_Trustees are also directors for the purposes of company law_ 

## **Staff** 

CEO: Rosie Eliot Deputy CEO: Sarah Williamson Volunteer Coordinator: Carol Coates Community Fundraiser: Amanda Strong Finance Assistant: Emma Smele Welfare & Events Coordinator: Sarah Folker Housekeeper: Katie Salmons 

## **Therapists** 

Lead Physiotherapist: Jane Cave-Gibbs Assistant Physiotherapist: Susan Watts Assistant Physiotherapist: Neil Tipping Reflexologist: Bev Such Massage Therapist: Stephanie Davis Counsellor: Lisa Scholefield Energy Therapy: Martin Davis Touch Therapy: Sarah Zebedee Foot Care Specialist: Kirsty Withey 

## **Volunteers** 

Oxygen Operators Receptionists Administrators Physiotherapy Assistants Charity Shop Support Team Trustees 

Fundraising was also particularly affected, especially due to lack of public engagement, but the fantastic hard working team of staff, volunteers and members managed to keep the charity active and secured much sought funding. 

The trustees would like to offer sincere thanks to the hard working team of staff, therapists and volunteers who helped to make 2021 as successful as we could have wished for. Our charity strives to bring a better quality of life to the members, their families, and carers and we will continue to flourish during 2022. 

**Mike Davidson Acting Chair** 



## **THERAPIES** 

We want to bring a better quality of life to all our members. We believe having regular physical, emotional and social therapies helps members to manage their health and lead a more fulfilled life. 

## **Physiotherapy** 


Physiotherapy has a vital role to play in helping people to cope with the daily challenge of living with MS. We use an approach that enables members to: 

- Learn to control and co-ordinate movement patterns 

- Reduce spasticity and encourage more normal movements 

- Regain functional abilities 

Physiotherapy treatment programmes are only available to members with MS and are tailored to the individual needs of each person. Using the basis of careful and detailed assessments, the physiotherapist draws up a treatment regime specific to each member. 

## **Oxygen Therapy** 

Oxygen is essential to every tissue in the body and any tissue injury requires oxygen for healing. Breathing oxygen under pressure causes the dilated and leaky blood vessels in MS to constrict back to normal size and reduce the swelling. At the same time, more oxygen is delivered into the bloodstream, increasing the amount available to help undertake repair. 

## **Massage Therapy** 

Massage is known to improve circulation. It relaxes tense muscles and is an excellent way to unwind and help restore a sense of well being and balance. Massage therapy for people with MS is an excellent way for individuals to relieve some of the tension that lives in their muscles on a daily basis. 

## **Pilates** 

Pilates exercises are low-impact but work every part of the body, which has a huge number of benefits for people with MS. Building strength and control of the muscles helps support the joints and can improve balance, posture and body awareness. It is particularly effective on tense or tight muscles and can help you to relax and just generally get everything moving. 

## **Reflexology** 

Reflexology aims to correct the three negative factors of congestion, inflammation and tension. 

- Congested conditions are responsible for bringing about growths 

- Inflammatory conditions are those such as colitis, bronchitis, or sinusitis 

- Tension is responsible for lowering the efficiency of the immune system 

Reflexology is a complementary therapy. The aims of this therapy are to improve and strengthen some of the weaknesses in the body that are caused through living with MS. In particular, bladder and bowel function improvements have been felt by many of our members. These improvements are believed to be achieved by targeting the problem area through ‘reflex’ points found in or around the feet and hands. 

## **Counselling** 

Counselling is an opportunity to talk through and share the emotional concerns and feelings people are experiencing. The counsellor’s role is to be supportive and to encourage people to find ways forward during turbulent times. Counselling can help with: 

- Anxiety or depression 

- Low self-esteem 

- Emotional problems 

- Relationship difficulties 

- Family or marital crises 

- Work related problems 

- • Bereavement 

- Personal development 

- 4 - 




## **FUNDRAISING** 

As a completely self-funding charity we are tasked with bringing in all running costs through donations and grants. We are supported greatly by our members donations and the fundraising department is always busy. However, 2021 was still in the grips of the pandemic and fundraising was limited under social restriction conditions. 

Among the few events of 2021 one of our members, Paula Carr, celebrated her 70th birthday and raised funds by completing a 15,000 ft skydive. Rosie Eliot celebrated ten years at the helm of the charity and completed a 10k sponsored run raising over £4,500. 

The High Sherriff of Wiltshire and Swindon, Sir Charles Hobhouse, chose the MS Centre as one of his charities of the year and hosted a garden party in wonderful sunshine at Monkton Farleigh Manor House. Lots of funds were raised, primarily through the fantastic dog show. 

**We received grants from the following organisations:** 

Leonard Laity Stoate Charitable Trust National Lottery Community Fund Wiltshire Community Foundation Warminster Town Council Trowbridge Town Council Wiltshire Council Radstock Lions 

A huge thank you to everyone who completed an event and raised much needed funds for us. 

**- 5 -** 



**MULTIPLE SCLEROSIS THERAPY CENTRE** 

## **THE DIFFERENCE WE MAKE** 

## Giving people with MS a better quality of life 

Longer term use of limbs through self management 

Better able Better to manage sleep, fatigue, management digestion, joint of good mental pain, vision and health clearer speech 

Physical and mental self management 

Improved Better control bladder / bowel of limbs, control, balance dexterity and and strength, manage fatigue, balance less joint pain 

Learning to cope with thoughts and worries 

Improved balance and core strength, calms mental health 

## 

Immediate Improved Release from Physical physical sleep and less stress and relief and relief fatigue anxiety satisfaction Physiotherapy Oxygen Therapy Counselling Other Therapies 

Fully accessible purpose-built centre 


Trained and qualified professional therapists 

Physical, social and emotional support for people with MS, their carers and families 

- 6 - 



## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **Independent examiner's report to the trustees of Multiple Sclerosis Therapy Centre (Wessex) Limited ('the Company')** 

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2021. 

## **Responsibilities and basis of report** 

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). 

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. 

## **Independent examiner's statement** 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 

1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)). 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Ian D Gillard FCA FCCA DipPFS PG Owen Limited Chartered Accountants 21A Market Place Warminster Wiltshire BA12 9AY 

Date: ............................................. 

7 



## **MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2021** 

|Unrestricted<br>funds<br>Notes<br>£<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>136,663<br>Other trading activities<br>2<br>50,196<br>Investment income<br>3<br>8,817<br>Other income<br>15,057<br>**Total**<br>210,733<br>**EXPENDITURE ON**<br>Raising funds<br>6,055<br>**Charitable activities**<br>4<br>Charitable activities<br>171,838<br>Depreciation<br>7,702<br>Direct Costs<br>60,193<br>**Total**<br>245,788<br>Net gains on investments<br>53,743<br>**NET INCOME**<br>18,688<br>**RECONCILIATION OF FUNDS**<br>**Total funds brought forward**<br>536,780<br>**TOTAL FUNDS CARRIED FORWARD**<br>555,468|Restricted<br>fund<br>£<br>10,000<br>-<br>-<br>-<br>10,000<br>-<br>-<br>3,885<br>-<br>3,885<br>-<br>6,115<br>33,001<br>39,116|2021<br>Total<br>funds<br>£<br>146,663<br>50,196<br>8,817<br>15,057<br>220,733<br>6,055<br>171,838<br>11,587<br>60,193<br>249,673<br>53,743<br>24,803<br>569,781<br>594,584|2020<br>Total<br>funds<br>£<br>328,900<br>77,170<br>6,187<br>26,421<br>438,678<br>8,240<br>167,630<br>15,087<br>57,588<br>248,545<br>13,359<br>203,492<br>366,289<br>569,781|
|---|---|---|---|



The notes form part of these financial statements 

8 



## **MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **BALANCE SHEET 31 DECEMBER 2021** 

|Notes<br>**FIXED ASSETS**<br>Tangible assets<br>8<br>Investments<br>9<br>**CURRENT ASSETS**<br>Cash at bank<br>**CREDITORS**<br>Amounts falling due within one year<br>10<br>**NET CURRENT ASSETS**<br>**TOTAL ASSETS LESS CURRENT**<br>**LIABILITIES**<br>**NET ASSETS**<br>**FUNDS**<br>11<br>Unrestricted funds<br>Restricted funds<br>**TOTAL FUNDS**|Unrestricted<br>funds<br>£<br>122,002<br>408,420<br>530,422<br>31,041<br>(5,995)<br>25,046<br>555,468<br>555,468|Restricted<br>fund<br>£<br>767<br>-<br>767<br>38,349<br>-<br>38,349<br>39,116<br>39,116|2021<br>Total<br>funds<br>£<br>122,769<br>408,420<br>531,189<br>69,390<br>(5,995)<br>63,395<br>594,584<br>594,584<br>555,468<br>39,116<br>594,584|2020<br>Total<br>funds<br>£<br>134,356<br>214,677<br>349,033<br>229,279<br>(8,531)<br>220,748<br>569,781<br>569,781<br>536,780<br>33,001<br>569,781|
|---|---|---|---|---|



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021. 

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006. 

The trustees acknowledge their responsibilities for 

- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and 

- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. 

The notes form part of these financial statements 

continued... 

9 



## **MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **BALANCE SHEET - continued 31 DECEMBER 2021** 

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. 

The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: 

............................................. M Davidson – Acting Chair 

The notes form part of these financial statements 

10 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021** 

## **1. ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value. 

## **Income** 

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. 

## **Expenditure** 

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. 

## **Tangible fixed assets** 

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. 

|Leasehold property|-  2% on cost|
|---|---|
|Improvements to leasehold|7.5% on cost|
|Oxygen chamber|-  5% on cost|
|Portable Oxygen machines|20% on cost|
|Gym equipment|10% on cost|
|Furniture and fittings|10% on cos|
|Other equipment|-  33% on cost|



## **Taxation** 

The charity is exempt from corporation tax on its charitable activities. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Designated funds are unrestricted funds earmarked by the trustees for a particular purpose.. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

## **Pension costs and other post-retirement benefits** 

The charitable company operates a defined contribution pension scheme.  Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate. 

11 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021** 

|**2.**<br>**OTHER TRADING ACTIVITIES**<br>Charity shops<br>Events<br>**3.**<br>**INVESTMENT INCOME**<br>Dividends<br>Interest<br>**4.**<br>**CHARITABLE ACTIVITIES COSTS**<br>Charitable activities<br>Depreciation<br>**5.**<br>**NET INCOME/(EXPENDITURE)**<br>Net income/(expenditure) is stated after charging/(crediting):<br>Depreciation - owned assets|2021<br>£<br>22,242<br>27,954<br>50,196<br>2021<br>£<br>8,811<br>6<br>8,817<br>2021<br>£<br>11,587|2020<br>£<br>25,064<br>52,106<br>77,170<br>2020<br>£<br>6,180<br>7<br>6,187<br>Support<br>costs<br>£<br>171,838<br>11,587<br>183,425<br>2020<br>£<br>15,087|
|---|---|---|
||||



## **6. TRUSTEES' REMUNERATION AND BENEFITS** 

There were no trustees' remuneration or other benefits for the year ended 31 December 2021 nor for the year ended 31 December 2020. 

## **Trustees' expenses** 

There were no trustees' expenses paid for the year ended 31 December 2021 nor for the year ended 31 December 2020. 

12 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021** 

|**7.**<br>**2020 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**<br>Unrestricted<br>Restricted<br>funds<br>fund<br>£<br>£<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>306,123<br>22,777<br>Other trading activities<br>77,170<br>-<br>Investment income<br>6,187<br>-<br>Other income<br>26,421<br>-<br>**Total**<br>415,901<br>22,777<br>**EXPENDITURE ON**<br>Raising funds<br>8,240<br>-<br>**Charitable activities**<br>Charitable activities<br>167,630<br>-<br>Depreciation<br>11,202<br>3,885<br>Direct Costs<br>53,806<br>3,782<br>**Total**<br>240,878<br>7,667<br>Net gains on investments<br>13,359<br>-<br>**NET INCOME**<br>188,382<br>15,110<br>**RECONCILIATION OF FUNDS**<br>**Total funds brought forward**<br>348,398<br>17,891<br>**TOTAL FUNDS CARRIED FORWARD**<br>536,780<br>33,001<br>**8.**<br>**TANGIBLE FIXED ASSETS**<br>Improvements<br>Leasehold<br>to<br>Oxygen<br>Other<br>property<br>property<br>chamber<br>equipment<br>£<br>£<br>£<br>£<br>**COST**<br>At 1 January 2021 and<br>31 December 2021<br>227,098<br>67,722<br>57,554<br>137,395<br>**DEPRECIATION**<br>At 1 January 2021<br>100,625<br>64,633<br>57,554<br>132,601<br>Charge for year<br>4,542<br>3,089<br>-<br>3,956<br>At 31 December 2021<br>105,167<br>67,722<br>57,554<br>136,557<br>**NET BOOK VALUE**<br>At 31 December 2021<br>121,931<br>-<br>-<br>838<br>At 31 December 2020<br>126,473<br>3,089<br>-<br>4,794|Total<br>funds<br>£<br>328,900<br>77,170<br>6,187<br>26,421<br>438,678<br>8,240<br>167,630<br>15,087<br>57,588<br>248,545<br>13,359<br>203,492<br>366,289<br>569,781<br>Totals<br>£<br>489,769<br>355,413<br>11,587<br>367,000<br>122,769<br>134,356|
|---|---|



13 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021** 

## **9. FIXED ASSET INVESTMENTS** 

|**MARKET VALUE**<br>At 1 January 2021<br>Additions<br>Change in value<br>At 31 December 2021<br>**NET BOOK VALUE**<br>At 31 December 2021<br>At 31 December 2020<br>There were no investment assets outside the UK.<br>**10.**<br>**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Trade creditors<br>Social security and other taxes<br>Other creditors<br>**11.**<br>**MOVEMENT IN FUNDS**|Listed<br>investments<br>£<br>214,677<br>140,000<br>53,743<br>408,420<br>408,420<br>214,677<br>2021<br>2020<br>£<br>£<br>2,132<br>6,130<br>2,868<br>1,679<br>995<br>722<br>5,995<br>8,531|
|---|---|



|**Unrestricted funds**<br>General fund<br>Designated Funds<br>**Restricted funds**<br>Restricted Fund<br>**TOTAL FUNDS**|At 1.1.21<br>£<br>120,543<br>416,237<br>536,780<br>33,001<br>569,781|Net<br>movement<br>in funds<br>£<br>(4,063)<br>22,751<br>18,688<br>6,115<br>24,803|Transfers<br>between<br>funds<br>£<br>57,512<br>(57,512)<br>-<br>-<br>-|At<br>31.12.21<br>£<br>173,992<br>381,476<br>555,468<br>39,116<br>594,584|
|---|---|---|---|---|



14 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021** 

## **11. MOVEMENT IN FUNDS - continued** 

Net movement in funds, included in the above are as follows: 

|**Unrestricted funds**<br>General fund<br>Designated Funds<br>**Restricted funds**<br>Restricted Fund<br>**TOTAL FUNDS**|Incoming<br>resources<br>£<br>210,733<br>-<br>210,733<br>10,000<br>220,733|Resources<br>expended<br>£<br>(238,086)<br>(7,702)<br>(245,788)<br>(3,885)<br>(249,673)|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>23,290<br>(4,063)<br>30,453<br>22,751<br>53,743<br>18,688<br>-<br>6,115<br>53,743<br>24,803|
|---|---|---|---|



## **Comparatives for movement in funds** 

|**Unrestricted funds**<br>General fund<br>Designated Funds<br>**Restricted funds**<br>Restricted Fund<br>**TOTAL FUNDS**|At 1.1.20<br>£<br>(8,170)<br>356,568<br>348,398<br>17,891<br>366,289|Net<br>movement<br>in funds<br>£<br>186,225<br>2,157<br>188,382<br>15,110<br>203,492|Transfers<br>between<br>funds<br>£<br>(57,512)<br>57,512<br>-<br>-<br>-|At<br>31.12.20<br>£<br>120,543<br>416,237<br>536,780<br>33,001<br>569,781|
|---|---|---|---|---|



Comparative net movement in funds, included in the above are as follows: 

|**Unrestricted funds**<br>General fund<br>Designated Funds<br>**Restricted funds**<br>Restricted Fund<br>**TOTAL FUNDS**|Incoming<br>resources<br>£<br>415,901<br>-<br>415,901<br>22,777<br>438,678|Resources<br>expended<br>£<br>(229,676)<br>(11,202)<br>(240,878)<br>(7,667)<br>(248,545)|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>-<br>186,225<br>13,359<br>2,157<br>13,359<br>188,382<br>-<br>15,110<br>13,359<br>203,492|
|---|---|---|---|



15 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021** 

## **11. MOVEMENT IN FUNDS - continued** 

A current year 12 months and prior year 12 months combined position is as follows: 

|**Unrestricted funds**<br>General fund<br>Designated Funds<br>**Restricted funds**<br>Restricted Fund<br>**TOTAL FUNDS**|At 1.1.20<br>£<br>(8,170)<br>356,568<br>348,398<br>17,891<br>366,289|Net<br>movement<br>in funds<br>£<br>182,162<br>24,908<br>207,070<br>21,225<br>228,295|Transfers<br>between<br>funds<br>£<br>-<br>-<br>-<br>-<br>-|At<br>31.12.21<br>£<br>173,992<br>381,476<br>555,468<br>39,116<br>594,584|
|---|---|---|---|---|



A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: 

|**Unrestricted funds**<br>General fund<br>Designated Funds<br>**Restricted funds**<br>Restricted Fund<br>**TOTAL FUNDS**|Incoming<br>resources<br>£<br>626,634<br>-<br>626,634<br>32,777<br>659,411|Resources<br>expended<br>£<br>(467,762)<br>(18,904)<br>(486,666)<br>(11,552)<br>(498,218)|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>23,290<br>182,162<br>43,812<br>24,908<br>67,102<br>207,070<br>-<br>21,225<br>67,102<br>228,295|
|---|---|---|---|



## **12. RELATED PARTY DISCLOSURES** 

During the year, two of the Trustees received therapies on an arms length basis. There were no other related party transactions for the year ended 31 December 2021. 

17 



**MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2021** 

## **13. DESIGNATED FUNDS** 

The purposes of the designated funds are as follows: 

* Fixed Assets Fund - a significant proportion of the Charity's resources are tied up in capital investment. Such resources are maintained in a designated fund in order to identify they are not available to expend on running costs. 

* Oxygen Tank Replacement Fund - the Trustees are keenly aware that the provision of oxygen therapy is of key importance to members. This fund has been set up to ensure resources will be  available to fund the replacement of the current facility when required. 

* Revenue Expenditure Contingency Fund - this fund has been created to protect the charity against the impact of any catastrophic event which removes its ability to operate in the short term. The fund is based on approximately six months committed costs. 

* COVID Recovery Fund - this fund has been created to help with the recovery from the effects on the Charity of the COVID-19 pandemic and the full and partial lockdowns which have resulted. 

17 



## **MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2021** 

|**INCOME AND ENDOWMENTS**<br>**Donations and legacies**<br>CFWS<br>Local Authorities<br>Members subscriptions<br>Donations from members<br>Gift Aid<br>Legacies<br>National Lottery<br>Roger & Jean Jefcoat Trust<br>Screwfix Foundation<br>Wiltshire Foundation Trust<br>Somerset Foundation Trust<br>**Other trading activities**<br>Charity shops<br>Events<br>**Investment income**<br>Dividends<br>Interest<br>**Other income**<br>Other<br>HMRC JRS Grants<br>**Total incoming resources**<br>**EXPENDITURE**<br>**Other trading activities**<br>Raising funds<br>**Direct Costs**<br>Oxygen and repairs to chamber<br>Professional fees and training<br>Assistance to enable members needing help to<br>come to the Centre|2021<br>£<br>1,300<br>8,283<br>4,298<br>108,217<br>4,056<br>10,509<br>10,000<br>-<br>-<br>-<br>-<br>146,663<br>22,242<br>27,954<br>50,196<br>8,811<br>6<br>8,817<br>3,120<br>11,937<br>15,057<br>220,733<br>6,055<br>20,681<br>36,335<br>3,177<br>60,193|2020<br>£<br>4,010<br>13,118<br>3,613<br>206,211<br>32,464<br>897<br>49,787<br>10,000<br>5,000<br>2,300<br>1,500<br>328,900<br>25,064<br>52,106<br>77,170<br>6,180<br>7<br>6,187<br>3,309<br>23,112<br>26,421<br>438,678<br>8,240<br>11,395<br>31,813<br>988<br>44,196|
|---|---|---|



This page does not form part of the statutory financial statements 

18 



## **MULTIPLE SCLEROSIS THERAPY CENTRE (WESSEX) LIMITED** 

## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2021** 

|**Support costs**<br> **Management**<br>Wages<br>Social security<br>Pensions<br>Electricity, water and insurance<br>Postage and telephone<br>Printing and stationery<br>Sundry expenses<br>Computer expenses<br>Travelling expenses<br> **Finance**<br>Bank charges<br>Subscriptions<br> **Information technology**<br>Repairs and renewals<br> **Depreciation**<br>Leasehold Property<br>Improvements to Leasehold Property<br>Other Equipment<br> **Governance costs**<br>Independent examination fee<br>Total resources expended<br>**Net (expenditure)/income before gains and**<br>**losses**<br>**Realised recognised gains and losses**<br>Realised gains/(losses) on fixed asset investments<br>**Net income**|2021<br>£<br>122,172<br>3,867<br>3,407<br>11,198<br>3,638<br>2,373<br>7,023<br>1,600<br>927<br>156,205<br>1,973<br>931<br>2,904<br>11,457<br>4,542<br>3,089<br>3,956<br>11,587<br>1,272<br>249,673<br>(28,940)<br>53,743<br>24,803|2020<br>£<br>121,155<br>4,626<br>3,401<br>9,610<br>3,132<br>2,298<br>8,815<br>1,285<br>1,020<br>155,342<br>1,965<br>743<br>2,708<br>21,832<br>4,542<br>5,079<br>5,466<br>15,087<br>1,140<br>248,545<br>190,133<br>13,359<br>203,492|
|---|---|---|



This page does not form part of the statutory financial statements 

19 

